Epizyme, Inc. (Nasdaq: EPZM) announced that Jason Rhodes, President and Chief Financial Officer, has resigned from the company, effective September ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE